PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.49%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
13.22%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
597.37%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
634.21%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
215.38%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
233.33%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
233.33%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.46%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
3.22%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
82.20%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
146.94%
FCF growth above 1.5x NXPI's 94.26%. David Dodd would verify if the firm’s strategic investments yield superior returns.
9.50%
10Y revenue/share CAGR under 50% of NXPI's 79.10%. Michael Burry would suspect a lasting competitive disadvantage.
-11.69%
Negative 5Y CAGR while NXPI stands at 77.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-40.47%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
100.19%
5Y OCF/share CAGR is similar to NXPI's 107.18%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
6.52%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
43.07%
Net income/share CAGR 1.25-1.5x NXPI's 36.73%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
1.45%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-45.24%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
137.33%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
51.12%
3Y equity/share CAGR 1.25-1.5x NXPI's 42.98%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
93.58%
Dividend/share CAGR of 93.58% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
33.51%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
2.52%
Below 50% of NXPI's 20.43%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-11.07%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-19.26%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.61%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.34%
Under 50% of NXPI's 3.20%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.15%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.90%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-31.95%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.